พบกับหัวข้อที่น่าสนใจอาทิ
- Update on the new therapeutic targets for dyslipidemia
- PCSK9 inhibitor: A new option to reduce LDL-cholesterol
- Mipomersen: A new antisense oligonucleotide (ASO) for the treatment of familial hypercholesterolemia
- SGLT2 inhibitors: New therapeutic agent for the treatment of type 2 DM
- Lacosamide: A functionalized amino acids for the treatment of partial epilepsy
- Oxycodone: An opioid agonist for the management of moderate to severe pain
- Apomorphine injection for the treatment of “off” episode in advanced Parkinson’s disease
- Dapoxetine: A new agent for the treatment of premature ejaculation
- Overview of promising drug targets for treating rheumatoid arthritis
- Kinase inhibitors: New approach to the treatment of rheumatoid arthritis
- Golimumab: A tumor necrosis factor (TNF) antagonist for the treatment of inflammatory arthritis
- Personalized vaccine: New approach for the treatment of prostate cancer
- Biological therapy: PK-PD considerations
- Formulary selection criteria for biosimilars: Considerations for Thai pharmacists
Associate Professor Chuthamanee C Suthisisang BPharm, PhD
Department of Pharmacology,
Faculty of Pharmacy, Mahidol University.
Title image from : http://images.indianexpress.c...